HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹522 Cr | ₹550 Cr | ₹442 Cr | ₹438 Cr | ₹486 Cr |
What is the latest Sundry Debtors ratio of HIKAL ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹550 Cr |
| Mar2023 | ₹442 Cr |
| Mar2022 | ₹438 Cr |
| Mar2021 | ₹486 Cr |
How is Sundry Debtors of HIKAL Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -5.07 | |
| Mar2024 | ₹550 Cr | 24.56 | |
| Mar2023 | ₹442 Cr | 0.93 | |
| Mar2022 | ₹438 Cr | -9.85 | |
| Mar2021 | ₹486 Cr | - | |
Compare Sundry Debtors of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,412.4 Cr | 2.3% | -13.8% | -45.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 2.3% |
-13.8% |
-45.3% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses